Motion Sickness Relief

Manufacturer
Chain Drug Consortium, LLC | Geri-Care Pharmaceutical Corp
Effective date
2021-12-02
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-01 22:24:57

Label at a glance#

ProductMotion Sickness Relief
Active ingredientMECLIZINE HYDROCHLORIDE
Label structure8 sections

Indications and uses

For the prevention and treatment of these symptoms associated with motion sickness • nausea • vomiting • dizziness

Dosage and administration

to prevent motion sickness, take the first dose one hour before starting activity not for frequent or prolonged use except on the advice of a doctor do not exceed recommended dose Adults and children 12 years if age and older Take 1-2 tablets once daily, or as directed by a doctor. Do not exceed 2 tablets in 24 hours.

Storage and handling

• TAMPER EVIDENT: Do not use if imprinted seal under cap is broken or missing. • store at room temperature 15˚-30˚C (59˚-86˚F) • protect from humidity

Label contents#

Full prescribing information#

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Meclizine HCI 25mg

Purpose

OTC - PURPOSE SECTION

Antiemetic

Uses

INDICATIONS & USAGE SECTION

For the prevention and treatment of these symptoms associated with motion sickness • nausea • vomiting • dizziness

Warnings

WARNINGS SECTION

Do not use in children under 12 years of age unless directed by a doctor.

Ask a doctor before use if you have

• breathing problems, such as emphysema or chronic bronchitis

• glaucoma

• difficulty urinating due to an enlarged prostate gland

A sk a doctor or pharmacist before use if you are taking sedatives or tranquilizers.

When using this product

• drowsiness may occur

• avoid alcoholic beverages

• alcohol, sedatives and tranquilizers may increase drowsiness

• use caution when driving a motor vehicle or operating machinery
I f pregnant or breast-feeding,ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • to prevent motion sickness, take the first dose one hour before starting activity
  • not for frequent or prolonged use except on the advice of a doctor
  • do not exceed recommended dose
Adults and children 12
years if age and older
Take 1-2 tablets once daily, or as directed by a doctor.
Do not exceed 2 tablets in 24 hours.

Other information

STORAGE AND HANDLING SECTION

• TAMPER EVIDENT:Do not use if imprinted seal under cap is broken or missing.

• store at room temperature 15˚-30˚C (59˚-86˚F)

• protect from humidity

Inactive ingredients

INACTIVE INGREDIENT SECTION

croscarmellose sodium, D and C yellow no. 10 lake, lactose, magnesium stearate, microcrystalline cellulose, silica, sodium starch glycolate, starch, stearic acid

package label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

778778

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
68016-77868016-778-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML · Source PDF

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
d22f319d-c2c7-3d99-e053-2a95a90a6d2361d29808-e2c0-7f9b-e053-2991aa0a46822021-12-02WarningsExact identifier
spl id: d22f319d-c2c7-3d99-e053-2a95a90a6d23
spl set id: 61d29808-e2c0-7f9b-e053-2991aa0a4682

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.